United States · FDA National Drug Code directory
Ondansetron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 17856-0672_41d71d34-d0bc-4d2b-e063-6294a90aa350
- Product NDC
- 17856-0672
- Form
- SOLUTION
- Composition / generic term
- Ondansetron Hydrochloride
- Labeler
- Atlantic Biologics Corp.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20071128
- Source listing expiry
- 20261231
Source-listed ingredients
- ONDANSETRON HYDROCHLORIDE — 4 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 60 SYRINGE in 1 CASE (17856-0672-1) / 2.5 mL in 1 SYRINGE · 17856-0672-1
- 120 SYRINGE in 1 CASE (17856-0672-2) / 2.5 mL in 1 SYRINGE · 17856-0672-2
- 120 SYRINGE in 1 CASE (17856-0672-3) / 2.5 mL in 1 SYRINGE · 17856-0672-3
- 72 CUP, UNIT-DOSE in 1 CASE (17856-0672-4) / 5 mL in 1 CUP, UNIT-DOSE · 17856-0672-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →